Skip to main content

Mitra Chem, Sun Chemical in battery deal

Mitra Chem, a specialist in lithium-ion battery materials, has formed a joint project with inks and pigments giant Sun Chemical to develop the first iron phosphate mass production capability in North America. This will be co-located with Mitra Chem's lithium iron phosphate (LFP) production.

BASF in biofumaric acid project

BASF has revealed that it is collaborating with three German universities on a project to make fumaric acid from the Basfia succiniciproducens bacterium by fermentation. The company uses fumaric acid as a chemical intermediate for various low carbon footprint products, including food and feed additives for, pharmaceutical raw materials and building blocks for polymers and detergents.

SynChem boosts Formosa’s presence

Formosa Laboratories, a Taiwan-based API supplier and CDMO, has completed the acquisition of SynChem, a contract research laboratory located in suburban Chicago. SynChem will now operate as SynChem-Formosa, with Dr W. Paul Mar continuing as CEO. Terms were not disclosed.

Trillium chooses Ineos site

Trillium Renewable Chemicals has chosen Ineos Nitriles’ Green Lake facility in Port Lavaca, Texas, as the site for its Project Falcon demonstration plant to convert plant-based glycerol into acrylonitrile. This should begin operations in early 2025 and will help to validate commercial-scale economics and product carbon footprint at scale, the company said.

DuPont plans three-way split

DuPont has announced a plan to separate into three separate, publicly traded companies over the course of the 18-24 months, subject to the satisfaction of customary conditions, including final board approval regulatory approvals and satisfactory completion of financing. Outgoing CEO and executive chairman Ed Breen (pictured) described this as “an extraordinary opportunity to deliver long-term, sustainable shareholder value”.

US puts further squeeze on WuXi AppTec

The US House of Representatives Committee on Oversight & Accountability committee has approved the Biosecure Act, which will require American companies to cease working with WuXi AppTec, among other Chinese biotechs, by 2032. This follows a vote on an earlier draft by the Senate’s Homeland Security & Governmental Affairs committee. The Act must now go through votes in both chambers and be signed into law by the President.

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU and the Bio-based Industries Consortium (BIC) that funds projects advancing competitive circular bio-based industries in Europe, has signed 31 grant agreements with project teams selected in the 2023 calls. As a result, 396 beneficiaries from 34 countries across the EU and beyond will receive nearly €215 million in funding to develop circular and sustainable bio-based consumer products and industrial systems to replace fossil-based ones.

Subscribe to Current issue